Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Change in Acquisitions & Divestments (2018 - 2026)

Ovid Therapeutics filings provide 7 years of Change in Acquisitions & Divestments readings, the most recent being $10.0 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments changed 0.0% to $10.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $42.0 million through Mar 2026, down 61.11% year-over-year, with the annual reading at $42.0 million for FY2025, 67.19% down from the prior year.
  • Change in Acquisitions & Divestments hit $10.0 million in Q1 2026 for Ovid Therapeutics, up from $5.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $60.0 million in Q4 2022 and bottomed at $5.0 million in Q4 2025.
  • Average Change in Acquisitions & Divestments over 5 years is $26.0 million, with a median of $25.0 million recorded in 2023.
  • The largest annual shift saw Change in Acquisitions & Divestments soared 280.0% in 2024 before it tumbled 86.84% in 2025.
  • Ovid Therapeutics' Change in Acquisitions & Divestments stood at $60.0 million in 2022, then crashed by 83.33% to $10.0 million in 2023, then soared by 280.0% to $38.0 million in 2024, then tumbled by 86.84% to $5.0 million in 2025, then soared by 100.0% to $10.0 million in 2026.
  • Per Business Quant, the three most recent readings for OVID's Change in Acquisitions & Divestments are $10.0 million (Q1 2026), $5.0 million (Q4 2025), and $10.0 million (Q3 2025).